Detailed information for compound 1434927

Basic information

Technical information
  • TDR Targets ID: 1434927
  • Name: 2-bromo-N-(2,3-dihydroindole-1-carbothioyl)be nzamide
  • MW: 361.256 | Formula: C16H13BrN2OS
  • H donors: 1 H acceptors: 1 LogP: 3.87 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1ccccc1Br)NC(=S)N1CCc2c1cccc2
  • InChi: 1S/C16H13BrN2OS/c17-13-7-3-2-6-12(13)15(20)18-16(21)19-10-9-11-5-1-4-8-14(11)19/h1-8H,9-10H2,(H,18,20,21)
  • InChiKey: NLIZZHPFSIROKI-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-bromo-N-(indoline-1-carbothioyl)benzamide
  • 2-bromo-N-(1-indolinyl-thioxomethyl)benzamide
  • 2-bromo-N-(2,3-dihydroindol-1-ylcarbothioyl)benzamide
  • MLS000392582
  • SMR000261505
  • STK113974
  • ZINC00675564
  • AN-329/41572182
  • ARONIS005928

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mus musculus RAR-related orphan receptor gamma Starlite/ChEMBL No references
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references
Influenza A virus Nonstructural protein 1 Starlite/ChEMBL No references
Homo sapiens nuclear factor, erythroid 2-like 2 Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Hypothetical protein Nonstructural protein 1   230 aa 202 aa 23.8 %
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.0041 0.5371 0.906
Brugia malayi hypothetical protein 0.002 0.0147 0.0147
Entamoeba histolytica hypothetical protein 0.0043 0.5929 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.2768 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.2768 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.2768 0.2768
Entamoeba histolytica hypothetical protein 0.0043 0.5929 0.5
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.5371 0.5371
Schistosoma mansoni transcription factor LCR-F1 0.0043 0.5929 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 1 1
Entamoeba histolytica hypothetical protein 0.0043 0.5929 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.2768 0.5
Brugia malayi hypothetical protein 0.0043 0.5929 0.5929
Toxoplasma gondii LsmAD domain-containing protein 0.003 0.2768 0.5
Loa Loa (eye worm) hypothetical protein 0.0041 0.5371 0.5371
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.2768 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.2768 0.5
Brugia malayi hypothetical protein 0.003 0.2768 0.2768
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 1 1
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.2768 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0043 0.5929 1
Leishmania major hypothetical protein, conserved 0.003 0.2768 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0043 0.5929 1
Schistosoma mansoni hypothetical protein 0.0043 0.5929 1
Entamoeba histolytica hypothetical protein 0.0043 0.5929 0.5
Loa Loa (eye worm) hypothetical protein 0.006 1 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 0.1 um PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 0.1 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 0.8913 um PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 2.8184 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 10 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 16.3601 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 18.526 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 23.1093 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 35.4813 uM PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.